New advances in the treatment of adult chronic immune thrombocytopenic purpura: role of thrombopoietin receptor-stimulating agents

References

• GeorgeJNWoolfSHRaskobGEIdiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of HematologyBlood19968813408704187
   PubMed Web of Science ®Google Scholar
• British Committee for Standards in Haematology General Haematology Task ForceGuidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancyBr J Haematol2003120457459612588344
   PubMed Web of Science ®Google Scholar
• CinesDBBlanchetteVSImmune thrombocytopenic purpuraN Engl J Med200234613995100811919310
   PubMed Web of Science ®Google Scholar
• WhippleASplenectomy as a therapeutic measure in thrombocytopenic purpura hæmorrhagicaSurg Gynecol Obstetr192642329341
   Google Scholar
• MeyersMMSBethellFHAdministration of ACTH in hypersplenic syndromesJ Lab Clin Med195036696596614795046
   PubMed Web of Science ®Google Scholar
• BethellFMMCMillerSBullockWHEffects of ACTH and cortisone on idiopathic thrombocytopenic purpuraTrans Assoc Am Physicians19516419920314884250
   PubMedGoogle Scholar
• VerlinMLarosRKJrPennerJATreatment of refractory thrombocytopenic purpura with cyclophosphamineAm J Hematol19761197104988746
   PubMed Web of Science ®Google Scholar
• SussmanLNAzathioprine in refractory idiopathic thrombocytopenic purpuraJAMA196720242592636072298
   PubMed Web of Science ®Google Scholar
• ProctorSJJacksonGCareyPStarkAShort-course alpha-interferon therapy in severe unresponsive immune thrombocytopenic purpuraLancet1988185919472895878
   PubMed Web of Science ®Google Scholar
• KelseyPRSchofieldKPGearyCGRefractory idiopathic thrombocytopenic purpura (ITP) treated with cyclosporineBr J Haematol19856011971984039943
   PubMed Web of Science ®Google Scholar
• HowardJHoffbrandAVPrenticeHGMehtaAMycophenolate mofetil for the treatment of refractory auto-immune haemolytic anaemia and auto-immune thrombocytopenia purpuraBr J Haematol2002117371271512028047
   PubMed Web of Science ®Google Scholar
• GodeauBOksenhendlerEBierlingPDapsone for autoimmune thrombocytopenic purpuraAm J Hematol199344170728342569
   PubMed Web of Science ®Google Scholar
• McMinnJRJrCohenSMooreJComplete recovery from refractory immune thrombocytopenic purpura in three patients treated with etanerceptAm J Hematol200373213514012749017
   PubMed Web of Science ®Google Scholar
• AhnYSHarringtonWJSimonSRMylvaganamRPallLMSoAGDanazol for the treatment of idiopathic thrombocytopenic purpuraN Engl J Med198330823139613996682484
   PubMed Web of Science ®Google Scholar
• GeorgeJNManagement of patients with refractory immune thrombocytopenic purpuraJ Thromb Haemost2006481664167216879206
   PubMed Web of Science ®Google Scholar
• PortieljeJEWestendorpRGKluin-NelemansHCBrandAMorbidity and mortality in adults with idiopathic thrombocytopenic purpuraBlood20019792549255411313240
   PubMed Web of Science ®Google Scholar
• GeorgeJNVeselySKImmune thrombocytopenic purpura-let the treatment fit the patientN Engl J Med2003349990390512944577
   PubMed Web of Science ®Google Scholar
• DameshekWMillerEBThe Megakaryocytes in idiopathic thrombocytopenic purpura, a form of hypersplenismBlood1946112751
   Web of Science ®Google Scholar
• StollDCinesDBAsterRHMurphySPlatelet kinetics in patients with idiopathic thrombocytopenic purpura and moderate thrombocytopeniaBlood19856535845884038614
   PubMed Web of Science ®Google Scholar
• Heyns AduPBadenhorstPNLotterMGPietersHWesselsPKotzeHFPlatelet turnover and kinetics in immune thrombocytopenic purpura: results with autologous 111In-labeled platelets and homologous 51Cr-labeled platelets differBlood198667186923940554
   PubMed Web of Science ®Google Scholar
• BallemPJSegalGMStrattonJRGernsheimerTAdamsonJWSlichterSJMechanisms of thrombocytopenia in chronic autoimmune thrombocytopenic purpura. Evidence of both impaired platelet production and increased platelet clearanceJ Clin Invest198780133403597777
   PubMed Web of Science ®Google Scholar
• GernsheimerTStrattonJBallemPJSlichterSJMechanisms of response to treatment in autoimmune thrombocytopenic purpuraN Engl J Med1989320159749802927480
   PubMed Web of Science ®Google Scholar
• KelemanECITanosBDemonstration and some properties of human thrombopoietin in thrombocythaemic seraActa Haem1958206350355
   Google Scholar
• De GabrieleGPeningtonDGPhysiology of the regulation of platelet productionBr J Haematol19671322022096019030
   PubMed Web of Science ®Google Scholar
• WendlingFVarletPCharonMTambourinPMPLV: a retrovirus complex inducing an acute myeloproliferative leukemic disorder in adult miceVirology198614922422463004028
   PubMed Web of Science ®Google Scholar
• Le ConiatMSouyriMVigonIWendlingFTambourinPBergerRThe human homolog of the myeloproliferative virus maps to chromosome band 1p34Hum Genet19898321941962550356
   PubMed Web of Science ®Google Scholar
• SouyriMVigonIPenciolelliJFHeardJMTambourinPWendlingFA putative truncated cytokine receptor gene transduced by the myeloproliferative leukemia virus immortalizes hematopoietic progenitorsCell1990636113711472175677
   PubMed Web of Science ®Google Scholar
• VigonIMornonJPCocaultLMolecular cloning and characterization of MPL, the human homolog of the v-mpl oncogene: identification of a member of the hematopoietic growth factor receptor superfamilyProc Natl Acad Sci U S A19928912564056441608974
   PubMed Web of Science ®Google Scholar
• MethiaNLouacheFVainchenkerWWendlingFOligodeoxynucleotides antisense to the proto-oncogene c-mpl specifically inhibit in vitro megakaryocytopoiesisBlood1993825139514017689867
   PubMed Web of Science ®Google Scholar
• GurneyALCarver-MooreKde SauvageFJMooreMWThrombocytopenia in c-mpl-deficient miceScience19942655177144514478073287
   PubMed Web of Science ®Google Scholar
• AlexanderWSRobertsAWNicolaNALiRMetcalfDDeficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietic receptor c-MplBlood1996876216221708630375
   PubMed Web of Science ®Google Scholar
• KimuraSRobertsAWMetcalfDAlexanderWSHematopoietic stem cell deficiencies in mice lacking c-Mpl, the receptor for thrombopoietinProc Natl Acad Sci U S A1998953119512009448308
   PubMed Web of Science ®Google Scholar
• de SauvageFJHassPESpencerSDStimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligandNature199436964815335388202154
   PubMed Web of Science ®Google Scholar
• LokSKaushanskyKHollyRDCloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivoNature199436964815655688202158
   PubMed Web of Science ®Google Scholar
• KaushanskyKLokSHollyRDPromotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietinNature199436964815685718202159
   PubMed Web of Science ®Google Scholar
• BartleyTDBogenbergerJHuntPIdentification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor MplCell1994777111711248020099
   PubMed Web of Science ®Google Scholar
• WendlingFMaraskovskyEDebiliNc-Mpl ligand is a humoral regulator of megakaryocytopoiesisNature199436964815715748202160
   PubMed Web of Science ®Google Scholar
• SohmaYAkahoriHSekiNMolecular cloning and chromosomal localization of the human thrombopoietin geneFEBS Let1994353157617926023
   PubMed Web of Science ®Google Scholar
• KaushanskyKThe molecular mechanisms that control thrombopoiesisJ Clin Invest2005115123339334716322778
   PubMed Web of Science ®Google Scholar
• BroudyVCLinNLKaushanskyKThrombopoietin (c-mpl ligand) acts synergistically with erythropoietin, stem cell factor, and interleukin-11 to enhance murine megakaryocyte colony growth and increases megakaryocyte ploidy in vitroBlood1995857171917267535585
   PubMed Web of Science ®Google Scholar
• van WilligenGGorterGAkkermanJWThrombopoietin increases platelet sensitivity to alpha-thrombin via activation of the ERK2-cPLA2 pathwayThromb Haemost200083461061610780326
   PubMed Web of Science ®Google Scholar
• AkkermanJWThrombopoietin and platelet functionSemin Thromb Hemost200632329530416673285
   PubMed Web of Science ®Google Scholar
• KaushanskyKThrombopoietin: a tool for understanding thrombopoiesisJ Thromb Haemost2003171587159212871295
   PubMed Web of Science ®Google Scholar
• AlexanderWSMetcalfDDunnARPoint mutations within a dimer interface homology domain of c-Mpl induce constitutive receptor activity and tumorigenicityEMBO J19951422556955788521814
   PubMed Web of Science ®Google Scholar
• MiyakawaYOdaADrukerBJRecombinant thrombopoietin induces rapid protein tyrosine phosphorylation of Janus kinase 2 and Shc in human blood plateletsBlood199586123277795229
   PubMed Web of Science ®Google Scholar
• DrachmanJGGriffinJDKaushanskyKThe c-Mpl ligand (thrombopoietin) stimulates tyrosine phosphorylation of Jak2, Shc, and c-MplJ Biol Chem199527010497949827534285
   PubMed Web of Science ®Google Scholar
• MiyakawaYDrachmanJGGallisBKaushanskyAKaushanskyKA structure-function analysis of serine/threonine phosphorylation of the thrombopoietin receptor, c-MplJ Biol Chem200027541322143221910918061
   PubMed Web of Science ®Google Scholar
• MiyakawaYOdaADrukerBJThrombopoietin induces tyrosine phosphorylation of Stat3 and Stat5 in human blood plateletsBlood19968724394468555464
   PubMed Web of Science ®Google Scholar
• GurneyALWongSCHenzelWJde SauvageFJDistinct regions of c-Mpl cytoplasmic domain are coupled to the JAK-STAT signal transduction pathway and Shc phosphorylationProc Natl Acad Sci U S A19959212529252967777500
   PubMed Web of Science ®Google Scholar
• NagataYTodokoroKThrombopoietin induces activation of at least two distinct signaling pathwaysFEBS Lett199537734975018549784
   PubMed Web of Science ®Google Scholar
• KaushanskyKDrachmanJGThe molecular and cellular biology of thrombopoietin: the primary regulator of platelet productionOncogene200221213359336712032774
   PubMed Web of Science ®Google Scholar
• YamadaMKomatsuNOkadaKKatoTMiyazakiHMiuraYThrombopoietin induces tyrosine phosphorylation and activation of mitogen-activated protein kinases in a human thrombopoietin-dependent cell lineBiochem Biophys Res Commun199521712302378526916
   PubMed Web of Science ®Google Scholar
• RojnuckarinPDrachmanJGKaushanskyKThrombopoietin-induced activation of the mitogen-activated protein kinase (MAPK) pathway in normal megakaryocytes: role in endomitosisBlood19999441273128210438715
   PubMed Web of Science ®Google Scholar
• HuntPLiYSNicholJLPurification and biologic characterization of plasma-derived megakaryocyte growth and development factorBlood19958625405477541666
   PubMed Web of Science ®Google Scholar
• HirayamaYSakamakiSMatsunagaTConcentrations of thrombopoietin in bone marrow in normal subjects and in patients with idiopathic thrombocytopenic purpura, aplastic anemia, and essential thrombocythemia correlate with its mRNA expression of bone marrow stromal cellsBlood199892146529639498
   PubMed Web of Science ®Google Scholar
• KosugiSKurataYTomiyamaYCirculating thrombopoietin level in chronic immune thrombocytopenic purpuraBr J Haematol19969337047068652398
   PubMed Web of Science ®Google Scholar
• TaharaTUsukiKSatoHA sensitive sandwich ELISA for measuring thrombopoietin in human serum: serum thrombopoietin levels in healthy volunteers and in patients with haemopoietic disordersBr J Haematol19969347837888703803
   PubMed Web of Science ®Google Scholar
• EmmonsRVReidDMCohenRLHuman thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destructionBlood19968710406840718639762
   PubMed Web of Science ®Google Scholar
• CorazzaFHermansCD’HondtSCirculating thrombopoietin as an in vivo growth factor for blast cells in acute myeloid leukemiaBlood200610762525253016317100
   PubMed Web of Science ®Google Scholar
• De GabrieleGPeningtonDGRegulation of platelet production: “thrombopoietin”Br J Haematol19671322102156019031
   PubMed Web of Science ®Google Scholar
• DahlenDDBroudyVCDrachmanJInternalization of the thrombopoietin receptor is regulated by 2 cytoplasmic motifsBlood2003103110210812623841
   PubMed Web of Science ®Google Scholar
• KuterDJRosenbergRDThe reciprocal relationship of thrombopoietin (c-Mpl ligand) to changes in the platelet mass during busulfan-induced thrombocytopenia in the rabbitBlood19958510272027307742532
   PubMed Web of Science ®Google Scholar
• FielderPJGurneyALStefanichERegulation of thrombopoietin levels by c-mpl-mediated binding to plateletsBlood1996876215421618630374
   PubMed Web of Science ®Google Scholar
• NagasawaTHasegawaYShimizuSSerum thrombopoietin level is mainly regulated by megakaryocyte mass rather than platelet mass in human subjectsBr J Haematol199810122422449609516
   PubMed Web of Science ®Google Scholar
• TerashiKOkaMOhdoSClose association between clearance of recombinant human granulocyte colony-stimulating factor (G-CSF) and G-CSF receptor on neutrophils in cancer patientsAntimicrob Agents Chemother199943121249869559
   PubMed Web of Science ®Google Scholar
• HarkerLATherapeutic cytokine stimulation of thrombocytopoiesisTransfus Sci199819214916210187040
   PubMedGoogle Scholar
• BasserRLRaskoJEClarkeKThrombopoietic effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in patients with advanced cancerLancet19963489037127912818909381
   PubMed Web of Science ®Google Scholar
• HokomMMLaceyDKinstlerOBPegylated megakaryocyte growth and development factor abrogates the lethal thrombocytopenia associated with carboplatin and irradiation in miceBlood19958612448644928541537
   PubMed Web of Science ®Google Scholar
• FanucchiMGlaspyJCrawfordJEffects of polyethylene glycol-conjugated recombinant human megakaryocyte growth and development factor on platelet counts after chemotherapy for lung cancerN Engl J Med199733664044099010146
   PubMed Web of Science ®Google Scholar
• KuterDJBegleyCGRecombinant human thrombopoietin: basic biology and evaluation of clinical studiesBlood2002100103457346912411315
   PubMed Web of Science ®Google Scholar
• Vadhan-RajSVerschraegenCFBueso-RamosCRecombinant human thrombopoietin attenuates carboplatin-induced severe thrombocytopenia and the need for platelet transfusions in patients with gynecologic cancerAnn Intern Med2000132536436810691586
   PubMed Web of Science ®Google Scholar
• Vadhan-RajSMurrayLJBueso-RamosCStimulation of megakaryocyte and platelet production by a single dose of recombinant human thrombopoietin in patients with cancerAnn Intern Med199712696736819139552
   PubMed Web of Science ®Google Scholar
• HarkerLAMarzecUMNovembreFTreatment of thrombocytopenia in chimpanzees infected with human immunodeficiency virus by pegylated recombinant human megakaryocyte growth and development factorBlood19989112442744339616135
   PubMed Web of Science ®Google Scholar
• HarkerLACRMarzecUMCherryJKCorrection of thrombocytopenia and ineffective platelet production in patients infected with human immunodeficiency virus (HIV) by PEG-rHuMGDF therapyBlood199892707a
   Web of Science ®Google Scholar
• KuterDJGoodnoughLTRomoJThrombopoietin therapy increases platelet yields in healthy platelet donorsBlood20019851339134511520780
   PubMed Web of Science ®Google Scholar
• GoodnoughLTKuterDJMcCulloughJProphylactic platelet transfusions from healthy apheresis platelet donors undergoing treatment with thrombopoietinBlood20019851346135111520781
   PubMed Web of Science ®Google Scholar
• NomuraSDanKHottaTFujimuraKIkedaYEffects of pegylated recombinant human megakaryocyte growth and development factor in patients with idiopathic thrombocytopenic purpuraBlood2002100272873012091377
   PubMed Web of Science ®Google Scholar
• RiceLNicholJLMcMillanRRoskosLKBacileMCyclic immune thrombocytopenia responsive to thrombopoietic growth factor therapyAm J Hematol200168321021411754405
   PubMed Web of Science ®Google Scholar
• HuaBZouNWangSZhuTZhaoYMultiple cycles of recombinant human thrombopoietin therapy in a patient with chronic refractory idiopathic thrombocytopenic purpuraBlood Coagul Fibrinolysis200516429129515870550
   PubMed Web of Science ®Google Scholar
• Fontenay-RoupieMDupontJMPicardFAnalysis of megakaryocyte growth and development factor (thrombopoietin) effects on blast cell and megakaryocyte growth in myelodysplasiaLeuk Res19982265275359678719
   PubMed Web of Science ®Google Scholar
• FerrajoliATalpazMKurzrockRThrombopoietin stimulates myelodysplastic syndrome granulocyte-macrophage and erythroid progenitor proliferationLeuk Lymphoma1998303–42792929713960
   PubMed Web of Science ®Google Scholar
• KizakiMMiyakawaYIkedaYLong-term administration of pegylated recombinant human megakaryocyte growth and development factor dramatically improved cytopenias in a patient with myelodysplastic syndromeBr J Haematol2003122576476712930386
   PubMed Web of Science ®Google Scholar
• MatsudaAMisumiMIshikawaMLong-term improvement of anaemia in a patient with aplastic anaemia by short-term administration of pegylated recombinant human megakaryocyte growth and development factorBr J Haematol2004125681881915180875
   PubMed Web of Science ®Google Scholar
• ArchimbaudEOttmannOGYinJAA randomized, doubleblind, placebo-controlled study with pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) as an adjunct to chemotherapy for adults with de novo acute myeloid leukemiaBlood199994113694370110572081
   PubMed Web of Science ®Google Scholar
• SchifferCAMillerKLarsonRAA double-blind, placebo-controlled trial of pegylated recombinant human megakaryocyte growth and development factor as an adjunct to induction and consolidation therapy for patients with acute myeloid leukemiaBlood20009582530253510753831
   PubMed Web of Science ®Google Scholar
• BolwellBVredenburghJOvermoyerBPhase 1 study of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in breast cancer patients after autologous peripheral blood progenitor cell (PBPC) transplantationBone Marrow Transplant200026214114510918423
   PubMed Web of Science ®Google Scholar
• LiJYangCXiaYThrombocytopenia caused by the development of antibodies to thrombopoietinBlood200198123241324811719360
   PubMed Web of Science ®Google Scholar
• BasserRLO’FlahertyEGreenMDevelopment of pancytopenia with neutralizing antibodies to thrombopoietin after multicycle chemotherapy supported by megakaryocyte growth and development factorBlood20029972599260211895799
   PubMed Web of Science ®Google Scholar
• LollarPPathogenic antibodies to coagulation factors. Part one: factor VIII and factor IXJ Thromb Haemost200421082109515219191
   PubMed Web of Science ®Google Scholar
• KeyNSInhibitors in congenital coagulation disordersBr J Haematol2004127437939115521914
   PubMed Web of Science ®Google Scholar
• CwirlaSEBalasubramanianPDuffinDJPeptide agonist of the thrombopoietin receptor as potent as the natural cytokineScience19972765319169616999180079
   PubMed Web of Science ®Google Scholar
• de SerresMEllisBDillbergerJEImmunogenicity of thrombopoietin mimetic peptide GW395058 in BALB/c mice and New Zealand white rabbits: evaluation of the potential for thrombopoietin neutralizing antibody production in manStem Cells199917420320910437983
   PubMed Web of Science ®Google Scholar
• DengBBanuNMalloyBAn agonist murine monoclonal anti-body to the human c-Mpl receptor stimulates megakaryocytopoiesisBlood1998926198119889731056
   PubMed Web of Science ®Google Scholar
• RiceLDrug evaluation: AMG-531 for the treatment of thrombocytopeniasCurr Opin Investig Drugs200679834841
   Google Scholar
• NicholJLAMG 531: an investigational thrombopoiesis-stimulating peptibodyPediatr Blood Cancer2006475 Suppl72372516933266
   PubMed Web of Science ®Google Scholar
• WangBNicholJLSullivanJTPharmacodynamics and pharmacokinetics of AMG 531, a novel thrombopoietin receptor ligandClin Pharmacol Ther200476662863815592334
   PubMed Web of Science ®Google Scholar
• BroudyVCLinNLAMG531 stimulates megakaryopoiesis in vitro by binding to MplCytokine2004252526014693160
   PubMed Web of Science ®Google Scholar
• NewlandACaulierMTKappers-KlunneMAn open-label, unit dose-finding study of AMG 531, a novel thrombopoiesis-stimulating peptibody, in patients with immune thrombocytopenic purpuraBr J Haematol2006135454755317061981
   PubMed Web of Science ®Google Scholar
• BusselJBKuterDJGeorgeJNAMG 531, a thrombopoiesis-stimulating protein, for chronic ITPN Engl J Med2006355161672168117050891
   PubMed Web of Science ®Google Scholar
• KuterDJBusselJBLyonsRMEfficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trialLancet2008371961039540318242413
   PubMed Web of Science ®Google Scholar
• GeorgeJNMathiasSDGoRSImproved quality of life for romiplostim-treated patients with chronic immune thrombocytopenic purpura: results from two randomized, placebo-controlled trialsBr J Haematol2009144340941519016720
   PubMed Web of Science ®Google Scholar
• BusselJBKuterDJPullarkatVLyonsRMGuoMNicholJLSafety and efficacy of long-term treatment with romiplostim in thrombocytopenic patients with chronic ITPBlood2009113102161217118981291
   PubMed Web of Science ®Google Scholar
• YanXQLaceyDFletcherFChronic exposure to retroviral vector encoded MGDF (mpl-ligand) induces lineage-specific growth and differentiation of megakaryocytes in miceBlood19958611402540337492757
   PubMed Web of Science ®Google Scholar
• UlichTRdel CastilloJSenaldiGSystemic hematologic effects of PEG-rHuMGDF-induced megakaryocyte hyperplasia in miceBlood19968712500650158652813
   PubMed Web of Science ®Google Scholar
• YanagidaMIdeYImaiAThe role of transforming growth factor-beta in PEG-rHuMGDF-induced reversible myelofibrosis in ratsBr J Haematol19979947397459432016
   PubMed Web of Science ®Google Scholar
• ChagraouiHKomuraETulliezMGiraudierSVainchenkerWWendlingFProminent role of TGF-beta 1 in thrombopoietin-induced myelofibrosis in miceBlood2002100103495350312393681
   PubMed Web of Science ®Google Scholar
• KuterDJMuftiGJBainBJHasserjianRPDavisWRutsteinMEvaluation of bone marrow reticulin formation in chronic immune thrombocytopenia (ITP) patients treated with romiplostimBlood20091143748375619671919
   PubMed Web of Science ®Google Scholar
• AmgenRomiplostim package insert2008 http://www.nplatenexus.com/pdfs/misc/nplate_pi.pdfAccessed on October 10, 2009
   Google Scholar
• KumagaiYFujitaTOzakiMPharmacodynamics and pharmacokinetics of AMG 531, a thrombopoiesis-stimulating peptibody, in healthy Japanese subjects: a randomized, placebo-controlled studyJ Clin Pharmacol200747121489149717925591
   PubMed Web of Science ®Google Scholar
• DuffyKJDarcyMGDelormeEHydrazinonaphthalene and azonaphthalene thrombopoietin mimics are nonpeptidyl promoters of megakaryocytopoiesisJ Med Chem200144223730374511606138
   PubMed Web of Science ®Google Scholar
• LuengoJIDuffyKJShawANDiscovery of SB-497115, a small-molecule thrombopoietin (TPO) receptor agonist for the treatment of thrombocytopeniaBlood (ASH Annual Meeting Abstracts)2004104112910
   Web of Science ®Google Scholar
• Erickson-MillerCDelormeEGiampaLBiological activity and selectivity for TPO receptor of the orally bioavailable, small molecule TPO receptor agonist, SB-497115Blood (ASH Annual Meeting Abstracts)2004104112912
   Web of Science ®Google Scholar
• Erickson-MillerCLDelormeETianSSPreclinical activity of eltrombopag (SB-497115), an oral, nonpeptide thrombopoietin receptor agonistStem Cells200927242443019038790
   PubMed Web of Science ®Google Scholar
• ErhardtJErickson-MillerCLTapleyPAgonist-induced platelet aggregation in vitroASH Annual Meeting Abstracts2004104113888
   Google Scholar
• JenkinsJMWilliamsDDengYPhase I clinical study of eltrombopag, an oral, non-peptide thrombopoietin receptor agonistBlood20071094739474117327409
   PubMed Web of Science ®Google Scholar
• WilliamsDDPengBBaileyCKEffects of food and antacids on the pharmacokinetics of eltrombopag in healthy adult subjects: Two single-dose, open-label, randomized-sequence, crossover studiesClin Ther200931476477619446149
   PubMed Web of Science ®Google Scholar
• BusselJBChengGSalehMNEltrombopag for the treatment of chronic idiopathic thrombocytopenic purpuraN Engl J Med2007357222237224718046028
   PubMed Web of Science ®Google Scholar
• McHutchisonJGDusheikoGShiffmanMLEltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis CN Engl J Med2007357222227223618046027
   PubMed Web of Science ®Google Scholar
• BusselJBProvanDShamsiTEffect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trialLancet2009373966464164819231632
   PubMed Web of Science ®Google Scholar
• GlaxoSmithKlinePROMACTA^® (eltrombopag) tablets2008 Available from: http://www.promactacares.com/prescribing_information.pdfAccessed on October 10, 222009
   Google Scholar
• RiceLTreatment of immune thrombocytopenic purpura: focus on eltrombopagBiologics2009315115719707404
   PubMedGoogle Scholar
• SuSFPengBWilliamsDA phase I study to investigate the pharmacokinetics (PK) and pharmacodynamics (PD) of an oral platelet growth factor (SB-559448) in healthy subjectsASH Annual Meeting Abstracts2006108111072
   Google Scholar
• DesjardinsRETempelDLLucekRKuterDJSingle and multiple oral doses of AKR-501 (YM477) increase the platelet count in healthy volunteersASH Annual Meeting Abstracts200610811477
   Google Scholar
• OritaTTsunodaHYabutaNA novel therapeutic approach for thrombocytopenia by minibody agonist of the thrombopoietin receptorBlood2005105256256615374889
   PubMed Web of Science ®Google Scholar
• FredericksonSRenshawMWLinBA rationally designed agonist antibody fragment that functionally mimics thrombopoietinProc Natl Acad Sci U S A200610339143071431216973749
   PubMed Web of Science ®Google Scholar
• NakamuraTMiyakawaYMiyamuraAA novel nonpeptidyl human c-Mpl activator stimulates human megakaryopoiesis and thrombopoiesisBlood2006107114300430716484588
   PubMed Web of Science ®Google Scholar